MUC1 and cancer: The first method utilizes synthetic glycopeptides believed to exist on cancer MUC1, conjugation of these glycopeptides to create an immunogen, immunization of mice (11), collection of anti-sera, and analysis of the binding of antibodies to MUC1 expressed on cancer cells by flow cytometry (FACS) analysis (12).